6533b871fe1ef96bd12d1b53

RESEARCH PRODUCT

Assessing psychological and supportive care needs in glioma patients - feasibility study on the use of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the Supportive Care Needs Survey Screening Tool (SCNS-ST9) in clinical practice

Mirjam RenovanzNaureen KericA.-k. HickmannAlf GieseA.-k. ReuterMarlene HechtnerMarlene HechtnerSusanne SingerJochem KönigMareile JankoM. Nadji-ohlJan CoburgerKaroline Kohlmann

subject

AdultMalemedicine.medical_specialtyPsychometricsYoung Adult03 medical and health sciences0302 clinical medicineQuality of life (healthcare)GliomamedicineHumansScreening toolAgedHealth Services Needs and DemandBrain Neoplasmsbusiness.industrySocial SupportGliomaMiddle Agedmedicine.diseaseTest (assessment)Clinical PracticeDistressOncologyHealth Care Surveys030220 oncology & carcinogenesisNeeds assessmentPhysical therapyFeasibility StudiesFemalebusinessPsychosocialNeeds Assessment030217 neurology & neurosurgery

description

Neuro-oncological patients experience high symptom and psychosocial burden. The aim was to test feasibility and practicability of the Supportive Care Needs Survey Short Form (SCNS-SF34-G) and the SCNS-Screening Tool (SCNS-ST9) to assess supportive care needs of neuro-oncological patients in clinical routine. A total of 173 patients, most with a primary diagnosis of high-grade glioma (81%), were assessed first using SCNS-SF34-G in comparison to two well-established patient-reported outcome measures, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQC30 + QLQ-BN20) and Distress Thermometer (DT). In a follow-up assessment, SCNS-ST9 was used in a subgroup (n = 90). Questionnaires were completed either with personal guidance offered (group A) or by patients alone (group B). Feasibility was compared between instruments and groups for possible associations with patient and treatment-related factors. Missing values occurred in similar frequencies in all instruments. Errors in completion occurred in SCNS-SF34-G in 20% and in SCNS-ST9 in 16%; difficulties in completion were observed more often in SCNS-SF34-G and SCNS-ST9 (39%) compared to DT and EORTC (13%, p < .001). Distress was found to be associated with difficulties in completion of SCNS (OR 1.4, [95% CI 1.1-1.9], p = .013). SCNS-SF34 and SCNS-ST9 are suitable tools for glioma patients as long as personal guidance is offered.

https://doi.org/10.1111/ecc.12598